» Articles » PMID: 34228645

HLA-E-restricted HIV-1-specific CD8+ T Cell Responses in Natural Infection

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2021 Jul 6
PMID 34228645
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

CD8+ T cell responses restricted by MHC-E, a nonclassical MHC molecule, have been associated with protection in an SIV/rhesus macaque model. The biological relevance of HLA-E-restricted CD8+ T cell responses in HIV infection, however, remains unknown. In this study, CD8+ T cells responding to HIV-1 Gag peptides presented by HLA-E were analyzed. Using in vitro assays, we observed HLA-E-restricted T cell responses to what we believe to be a newly identified subdominant Gag-KL9 as well as a well-described immunodominant Gag-KF11 epitope in T cell lines derived from chronically HIV-infected patients and also primed from healthy donors. Blocking of the HLA-E/KF11 binding by the B7 signal peptide resulted in decreased CD8+ T cell responses. KF11 presented via HLA-E in HIV-infected cells was recognized by antigen-specific CD8+ T cells. Importantly, bulk CD8+ T cells obtained from HIV-infected individuals recognized infected cells via HLA-E presentation. Ex vivo analyses at the epitope level showed a higher responder frequency of HLA-E-restricted responses to KF11 compared with KL9. Taken together, our findings of HLA-E-restricted HIV-specific immune responses offer intriguing and possibly paradigm-shifting insights into factors that contribute to the immunodominance of CD8+ T cell responses in HIV infection.

Citing Articles

HLA-E-restricted Hantaan virus-specific CD8 T cell responses enhance the control of infection in hemorrhagic fever with renal syndrome.

Tang K, Zhang Y, Li X, Zhang C, Jia X, Hu H Biosaf Health. 2025; 5(5):289-299.

PMID: 40078905 PMC: 11895001. DOI: 10.1016/j.bsheal.2023.06.002.


Association between human leukocyte antigen E expression and outcomes in solid tumors: a systematic review and meta-analysis.

Benitez Fuentes J, Bartolome Arcilla J, Lazaro Sanchez A, de Luna Aguilar A, Mohamed Mohamed K, Guevara-Hoyer K Front Oncol. 2025; 15:1525924.

PMID: 40066089 PMC: 11891020. DOI: 10.3389/fonc.2025.1525924.


HLA-E: Immune Receptor Functional Mechanisms Revealed by Structural Studies.

Gillespie G, Quastel M, McMichael A Immunol Rev. 2025; 329(1):e13434.

PMID: 39753525 PMC: 11698700. DOI: 10.1111/imr.13434.


Innate Immune Cell Functions Contribute to Spontaneous HIV Control.

Huber A, Baas F, van der Ven A, Dos Santos J Curr HIV/AIDS Rep. 2024; 22(1):6.

PMID: 39614998 PMC: 11608392. DOI: 10.1007/s11904-024-00713-0.


Viral sequence determines HLA-E-restricted T cell recognition of hepatitis B surface antigen.

Murugesan G, Paterson R, Kulkarni R, Ilkow V, Suckling R, Connolly M Nat Commun. 2024; 15(1):10126.

PMID: 39578466 PMC: 11584656. DOI: 10.1038/s41467-024-54378-9.


References
1.
Fresnay S, McArthur M, Magder L, Darton T, Jones C, Waddington C . Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans. J Transl Med. 2016; 14:62. PMC: 4772330. DOI: 10.1186/s12967-016-0819-7. View

2.
Nattermann J, Nischalke H, Hofmeister V, Kupfer B, Ahlenstiel G, Feldmann G . HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther. 2005; 10(1):95-107. DOI: 10.1177/135965350501000107. View

3.
Jorgensen P, Livbjerg A, Hansen H, Petersen T, Hollsberg P . Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients. PLoS One. 2012; 7(9):e46120. PMC: 3457977. DOI: 10.1371/journal.pone.0046120. View

4.
Lampen M, Hassan C, Sluijter M, Geluk A, Dijkman K, Tjon J . Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2. Mol Immunol. 2012; 53(1-2):126-31. DOI: 10.1016/j.molimm.2012.07.009. View

5.
Kan-Mitchell J, Bajcz M, Schaubert K, Price D, Brenchley J, Asher T . Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol. 2006; 176(11):6690-701. DOI: 10.4049/jimmunol.176.11.6690. View